Filter
28
Featured
Language
Document type
Guidelines
12
No document type
12
Manuals
2
Resource Platforms
1
Fact sheets
1
Countries / Regions
East and Southern Africa
3
Africa
3
Sierra Leone
2
Latin America and the Carribbean
2
Liberia
2
Ghana
1
Nigeria
1
Mozambique
1
Germany
1
West and Central Africa
1
Angola
1
Authors & Publishers
World Health Organization WHO
11
World Health Organization
4
Regional Office for Africa
3
Pan American Health Organisation PAHO
2
UNITAID
2
Pan American Health Organization PAHO
1
World Health Organization (WHO)
1
World Health Organisation (WHO)
1
UNITAID Secretariat, World Health Organization
1
THT Books
1
A.Hill, T. Swan and K.Timmermans
1
Africa CDC Centres for Disease Control and Prevention
1
Organización Panamericana de la Salud
1
Organización Mundial de la Salud OMS
1
Organisation Mondiale de la Santé OMS
1
Francis Aboagye-Nyame, Heather Alexander, Zelalem Gizachew Belachew et al.
1
Cheesbrough, M.
1
Centers for Disease control and Prevention
1
Bundesinstitut für Arzneimittel und Medizinprodukte
1
Bernard M. Branson, S. Michele Owen, Laura G. Wesolowski et
1
African Union
1
World Health Organization, Regional Office for the Americas
1
Publication Years
Category
Virology
28
COVID-19
5
Hepatitis
2
Bacteriology
1
General Guidelines
1
MPOX - Monkeypox
1
Yellow Fever
1
Parasitology
1
Laboratory Technologies
1
HIV & STI
1
Toolboxes
Diagnostics & Laboratory Guidance
13
Country specific documents
5
Laboratory Guidance
5
Genomic sequencing
4
Laboratory & Diagnostics
2
Zika
2
Laboratory & Sampling
2
Laboratory
1
Access to treatment and laboratory
1
MPOX - Monkeypox
1
Scientific & Research Studies
1
Rapid Response
1
Laboratory
1
Laboratory
1
Public Health
1
Yellow Fever Prevention & Control
1
Yellow Fever
1
Clinical Aspects, Treatment & Prevention
1
HIV testing & services
1
Clinical Aspects
1
July 2018 This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United... more
This algorithm is addressed to laboratories with established capacity(molecular, antigenic and/orserological) to detect dengue (DENV), Zika (ZIKV), and chikungunya(CHIKV) as part of the differential diagnosis for arborviruses. A BSL2 containment level is required to handle suspected samples.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi- nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim- i... more
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China. 19 March 2020
Tests zur Detektion einer Infektion mit SARS-CoV-2 (neuartiges Coronavirus) sowie zum Nachweis von Antikörpern gehören zu den sog. In-vitro-Diagnostika (IVD). Das erstmalige Inverkehrbringen von In-vitro-Diagnostika auf dem deutschen Markt ist nach §§ 25 und 30 Medizinproduktegesetz (MPG) anzeig... more
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga... more
8 January 2021 Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int... more
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid... more
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid... more
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta... more
To meet the need for laboratory diagnosis to be integrated in community care, the new 2022 Update describes point-of-care tests that can be performed both in district laboratories and peripheral healthcare facilities by non-specialist staff. Also included are recently developed self-tests.